Amrize (NYSE:AMRZ) Receives “Underperform” Rating from Bank of America

Amrize (NYSE:AMRZ)‘s stock had its “underperform” rating reissued by research analysts at Bank of America in a note issued to investors on Wednesday, Benzinga reports. They currently have a $40.00 price objective on the stock, down from their prior price objective of $50.00. Bank of America‘s price objective points to a potential downside of 6.52% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Sanford C. Bernstein reiterated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Morgan Stanley set a $63.00 price objective on Amrize and gave the stock an “overweight” rating in a research report on Monday, June 22nd. Citigroup dropped their price objective on Amrize from $66.00 to $58.00 and set a “buy” rating on the stock in a research note on Tuesday, August 11th. Finally, Royal Bank Of Canada lowered Amrize from a “sector perform” rating to an “underperform” rating and cut their target price for the company from $60.00 to $48.00 in a research report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $57.50.

Amrize Trading Down 2.1%

Shares of AMRZ stock opened at $42.79 on Wednesday. Amrize has a 1-year low of $42.72 and a 1-year high of $65.94. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The stock has a market cap of $23.67 billion, a price-to-earnings ratio of 19.72, a PEG ratio of 0.97 and a beta of 0.12. The stock has a 50-day moving average of $49.11 and a 200-day moving average of $53.52.

Amrize (NYSE:AMRZ) last announced its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The company had revenue of $3.49 billion during the quarter. On average, equities research analysts forecast that Amrize will post 2.74 earnings per share for the current year.

Insider Buying and Selling at Amrize

In other news, Director Jacques Wolf Sanche bought 4,150 shares of the stock in a transaction dated Wednesday, August 26th. The stock was bought at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the acquisition, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. This trade represents a 73.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Jaime Hill purchased 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The shares were purchased at an average cost of $47.12 per share, for a total transaction of $70,680.00. Following the completion of the transaction, the insider directly owned 29,698 shares of the company’s stock, valued at $1,399,369.76. This represents a 5.32% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 18,983 shares of company stock worth $884,535. 0.54% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Amrize

Several institutional investors and hedge funds have recently added to or reduced their stakes in AMRZ. Geode Capital Management LLC purchased a new position in shares of Amrize in the 2nd quarter worth approximately $265,000. M&T Bank Corp bought a new position in shares of Amrize in the second quarter valued at approximately $205,000. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Amrize during the second quarter valued at approximately $3,870,000. Gabelli Funds LLC bought a new stake in Amrize during the second quarter worth $1,083,000. Finally, AXA S.A. bought a new stake in Amrize during the second quarter worth $1,065,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.